Medication info
Ciplox Tablets (Ciprofloxacin Hydrochloride Hydrate)

Ciplox Tablets (Ciprofloxacin Hydrochloride Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Ciprofloxacin Hydrochloride Hydrate›291mg / 1 tablet
Manufacturer / importer
Jungheon Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201903855 · Approved 2019.06.13

Summary

Main use
Treatment of genitourinary, respiratory and otolaryngologic, and other infections (abdominal, skin, eye, etc.)
Who takes it
Adults
Adult dose
○ The usual adult dose is 250 ~ 500 mg of ciprofloxacin per dose, administered orally twice daily between meals. For severe complicated infections, the dose may be increased to 750 mg per dose twice daily. Acute infections are usually treated for 5 ~ 10 days, and treatment should continue for at least 3 days after symptoms have resolved. ○ Patients with renal impairment 1) Creatinine clearance > 50 mL/min: Administer the usual dose 2) 30 ~ 50 mL/min: Administer 250 ~ 500 mg per dose twice daily 3) 5 ~ 29 mL/min: Administer 250 ~ 500 mg every 18 hours 4) Patients receiving hemodialysis or peritoneal dialysis: Administer 250 ~ 500 mg per dose once daily after dialysis 5) If only serum creatinine is known, creatinine clearance can be calculated using the following formula. Men: {body weight(kg) × (140-age)}/ {72 × serum creatinine(mg/dL)} Women: 0.85 × the value calculated for men 6) For severe infections, the dose per administration may be increased to 750 mg even in patients with severe renal impairment; however, the patient's condition must be monitored carefully after administration. Adjust the dose appropriately according to symptoms.

Ingredients

Manufacturer
Jungheon Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of genitourinary, respiratory and otolaryngologic, and other infections (abdominal, skin, eye, etc.)

  • Acute bronchitis
  • respiratory infections
  • community-acquired pneumonia
  • pharyngitis
  • tonsillitis
  • laryngitis
  • otitis externa
  • chronic cholesteatomatous otitis media
  • chronic otitis media
  • bacterial prostatitis
  • acute simple cystitis
  • acute pyelonephritis
View approved original text

This medication is effective against various bacteria, including Escherichia coli, Shigella, and Salmonella, and is used for respiratory infections excluding acute bronchitis, as well as community-acquired pneumonia. It is also effective for ear, nose, and throat infections (pharyngitis, tonsillitis, laryngitis), bacterial prostatitis, acute simple cystitis, and acute pyelonephritis. It is also used for gonococcal cervicitis and urethritis, gastrointestinal infections, infections of the bile duct, skin and soft tissue infections, and osteoarticular infections. It can also be used to treat gynecological infections, peritonitis, fistulitis, chalazion, and inflammatory conditions. However, as a fluoroquinolone antibiotic, there is a possibility of severe adverse reactions, so it should only be used when there are no other treatment options available for acute bacterial sinusitis, chronic bronchitis, exacerbations of chronic obstructive pulmonary disease, and acute otitis media. This medication is used to treat various bacterial infections.

How to take

Adult dose

○ The usual adult dose is 250 ~ 500 mg of ciprofloxacin per dose, administered orally twice daily between meals. For severe complicated infections, the dose may be increased to 750 mg per dose twice daily. Acute infections are usually treated for 5 ~ 10 days, and treatment should continue for at least 3 days after symptoms have resolved. ○ Patients with renal impairment 1) Creatinine clearance > 50 mL/min: Administer the usual dose 2) 30 ~ 50 mL/min: Administer 250 ~ 500 mg per dose twice daily 3) 5 ~ 29 mL/min: Administer 250 ~ 500 mg every 18 hours 4) Patients receiving hemodialysis or peritoneal dialysis: Administer 250 ~ 500 mg per dose once daily after dialysis 5) If only serum creatinine is known, creatinine clearance can be calculated using the following formula. Men: {body weight(kg) × (140-age)}/ {72 × serum creatinine(mg/dL)} Women: 0.85 × the value calculated for men 6) For severe infections, the dose per administration may be increased to 750 mg even in patients with severe renal impairment; however, the patient's condition must be monitored carefully after administration. Adjust the dose appropriately according to symptoms.

Precautions

This medication can cause serious adverse reactions such as tendinitis or tendon rupture, peripheral neuropathy, and central nervous system effects, so administration must be stopped immediately if such symptoms appear. In particular, patients with severe myasthenia gravis may experience worsening symptoms due to this medication and should not use it. This drug is used to treat specific bacterial infections and should be used cautiously and only when no alternative treatment options are available. Elderly patients, renal impairment patients, and patients taking corticosteroids are at increased risk of tendon rupture and should avoid combination therapy. Pregnant women, breastfeeding women, adolescents under 18, and patients with epilepsy should not use this medication. Additionally, the risk of adverse effects increases when taken with certain medications such as tizanidine or ketoprofen, so these should not be combined. Care should be taken when using this drug in patients with severe renal impairment, seizure history, elderly patients, or patients with central nervous system disorders. This medication can cause various adverse reactions, and caution is needed as side effects such as skin rash, gastrointestinal disorders, neurological disorders, liver function abnormalities, musculoskeletal pain, and kidney problems have been reported. Particularly, if diarrhea or abdominal pain occurs, there may be a risk of serious intestinal conditions such as pseudomembranous colitis, and consultation with a physician is necessary. This medication may cause hypersensitivity reactions to sunlight, so strong sunlight or artificial UV exposure should be avoided, and administration should be stopped if any unusual symptoms occur. Additionally, if sensory abnormalities appear, patients should consult a specialist. This medication could affect driving or machine operation capabilities, so caution is advised, especially when taken with alcohol. Patients with heart-related issues or those at risk of QT interval prolongation should exercise additional caution when using this medication. Diabetic patients requiring blood sugar control should monitor for fluctuations in blood sugar and check their levels regularly. This medication often has many drug interactions, so it is crucial to consult a physician or pharmacist when taken with theophylline, warfarin, diabetes medications, and immunosuppressants. Pregnant or nursing women should either avoid this medication or stop breastfeeding, and it is not to be used in growing children or adolescents. Elderly patients may have increased drug concentrations due to declining kidney function, thus dosage and administration intervals should be adjusted. In case of overdose, renal function should be monitored carefully, and appropriate treatment should be given if necessary. Medications should be stored in a tightly sealed container to prevent air exposure and kept at room temperature between 1 and 30 degrees Celsius. Proper storage can prolong the drug's efficacy.

Side effects

Tendinitis, tendon rupture, peripheral neuropathy, central nervous system effects, exacerbation of myasthenia gravis, fungal superinfection, antibiotic-associated colitis, eosinophilia, thrombophlebitis, leukopenia, anemia, neutropenia, leukocytosis, thrombocytopenia, thrombocytosis, red blood cell reduction, hemoglobin reduction, hematocrit level reduction, granulocyte reduction, leukolysis, hemolytic anemia, agranulocytosis, pancytopenia, bone marrow suppression, increased INR value, syndrome of inappropriate antidiuretic hormone secretion, allergic reaction, allergic edema, angioedema, anaphylactic reaction, anaphylactoid shock, serum sickness-like reaction, decreased appetite, reduced food intake, increased serum alkaline phosphatase, hyperglycemia, hypoglycemia, increased lipase, abnormal prothrombin levels, increased amylase, psychomotor agitation, anxiety, confusion, disorientation, emotional instability, abnormal dreams, depression, hallucinations, psychotic reaction, toxic psychosis, headache, dizziness, sleep disorders, taste disorders, insomnia, sensory abnormalities, sensory loss, loss of taste, tremor, convulsions, vertigo, mental confusion, seizures, drowsiness, migraine, coordination impairment, olfactory disorders, anosmia, hypersensitivity, increased intracranial pressure, ataxia, polyneuropathy, visual disturbances, color vision changes, diplopia, tinnitus, hearing loss, transient hearing loss, hearing impairment, tachycardia, vasodilation, hypotension, syncope, vasculitis, QT prolongation, ventricular tachycardia, Torsades de Pointes, dyspnea, laryngeal edema, nausea, diarrhea, appetite loss, gastric discomfort, vomiting, gastrointestinal and abdominal pain, abdominal distension, dyspepsia, colitis accompanied by hematochezia, stomatitis, oral candidiasis, gastrointestinal candidiasis, pancreatitis, abnormal liver function tests, increased bilirubin, liver dysfunction, jaundice, hepatitis, biliary obstructive jaundice, hepatic necrosis, rash, itching, urticaria, photosensitivity, vesicles, petechiae, erythema multiforme, fixed drug eruption, acute generalized exanthematous pustulosis, arthralgia, musculoskeletal pain, myalgia, arthritis, increased muscle tone and cramps, joint swelling, muscle weakness, partial or complete tendon rupture, renal impairment, hematuria, crystalluria, interstitial nephritis, vaginal candidiasis, unexplained pain, discomfort, fever, asthenia, edema, sweating, gait disorders, maculopapular rash, purpuric rash, injection site rash, injection site itching, injection site urticaria, aortic aneurysm, aortic dissection, valvular regurgitation, valvular insufficiency, spasms, elevated intracranial pressure, dizziness, tremor, depression, psychotic reactions, suicidal thoughts, suicide attempts, self-harm behavior, pseudomembranous colitis, photosensitivity reactions, sensory abnormalities, sensory reduction, perceptual disorders, muscle weakness, rhabdomyolysis, interstitial pneumonia, visual impairment, acute kidney failure, shock, hypotension, chest tightness, cough, eosinophilia, interstitial pneumonia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air ingress and should be kept at room temperature between 1 and 30 degrees Celsius. Storing it this way helps to maintain the drug's effectiveness for a longer duration.

Appearance and packaging

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.